|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT02746107 |
|
Date of registration:
|
18/04/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.
|
|
Scientific title:
|
RCT Concerning the Intention to Prescribe/Take Oral Anticoagulants for Atrial Fibrillation Depending on the Number of Risk Diagrams (w Treatment +/- w/Out Treatment), and Number of Years (1 or 5) for the Estimation of the Risk of Stroke. |
|
Date of first enrolment:
|
March 2016 |
|
Target sample size:
|
968 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02746107 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Romania
| | | | | | | |
|
Contacts
|
|
Name:
|
Cristian Baicus, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Carol Davila University of Medicine and Pharmacy Bucharest - Colentina Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- physicians who prescribe anticoagulant treatment for atrial fibrillation (cardiology,
internal medicine, family medicine, hematology) or who deal with patients with stroke
(neurology, pathology) or bleeding (gastroenterology)
Exclusion Criteria:
- physicians who never prescribe anticoagulant treatments, or do not deal with patients
with stroke or bleeding because of anticoagulants
Age minimum:
24 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Stroke
|
|
Atrial Fibrillation
|
|
Intervention(s)
|
|
Other: decision aid
|
|
Primary Outcome(s)
|
|
Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Number of Decision Aid Diagrams
[Time Frame: after seeing the decision aid (5 min)]
|
|
Secondary ID(s)
|
|
Studiul Cozia
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|